查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1679772

核酸萃取儀器和試劑市場報告：趨勢、預測和競爭分析（至 2031 年）

Nucleic Acid Extraction Instrument and Reagent Market Report: Trends, Forecast and Competitive Analysis to 2031
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

全球核酸萃取儀器和試劑市場前景光明，在學術研究機構、醫院和診斷中心、製藥和生物技術以及受託研究機構市場都存在機會。預計全球核酸萃取設備和試劑市場在 2025 年至 2031 年期間的複合年成長率為 10.4%。該市場的主要驅動力是對個人化治療的興趣日益濃厚、慢性病發病率不斷上升以及醫學診斷技術的不斷發展。

  • Lucintel 預測設備將成為所有類型中成長最快的。
  • 根據最終用途，預計學術研究機構將實現最高成長。
  • 按地區分類，預計北美將實現最高成長。

核酸萃取設備及試劑市場的策略性成長機會

由於技術進步和對高效診斷解決方案的需求不斷增加，核酸萃取設備和試劑市場已具備成長的條件。公司可以利用多種策略機會來滿足不斷變化的市場需求，並將其業務範圍擴展到醫療保健、研究和生物技術等各個領域。

  • 拓展新興市場：隨著新興市場醫療基礎設施的發展，對核酸萃取技術的需求日益增加。透過對這些地區進行策略性投資，公司可以提供適合當地需求的經濟實惠且易於取得的解決方案。與當地分銷商和醫療保健提供者建立夥伴關係有助於加強市場滲透並加速成長。
  • 開發客自訂解決方案：客製化核酸萃取儀器和試劑以適應特定應用和用戶需求具有巨大的成長潛力。透過與研究機構和臨床實驗室合作，製造商可以針對不同的樣本類型和提取方法設計專門的產品，從而提高用戶滿意度和市場競爭力。
  • 人工智慧和機器學習的整合：將人工智慧 (AI) 和機器學習技術整合到核酸萃取過程中，為提高效率和準確性提供了機會。這些技術可以最佳化萃取通訊協定，提高產量並減少處理時間，對於尋求高效能解決方案的現代實驗室來說，它們具有吸引力。
  • 關注個人化醫療：個人化醫療的興起為核酸提取公司帶來了獨特的機會。由於基因組學在個人化醫療中發揮關鍵作用，對高品質核酸萃取的需求日益增加。開發支持基因組研究和精準醫療的強大解決方案可以使公司處於這個不斷成長的市場的前沿。
  • 夥伴關係和協作：與生物技術、學術和診斷公司建立策略夥伴關係可以促進創新並擴大市場範圍。這項合作研究將促進尖端萃取技術的發展，擴大核酸檢測在癌症研究、感染疾病診斷、基因研究等多個領域的應用。

由於技術進步和全球需求的不斷成長，核酸萃取設備和試劑市場提供了眾多策略性成長機會。專注於新興市場、客製化解決方案和人工智慧等創新技術可以幫助公司在競爭中取得成功。此外，合作與夥伴關係可以增強產品供應並擴大市場範圍，確保公司能夠充分滿足醫療保健和研究領域不斷變化的需求。隨著市場的不斷發展，抓住這些機會對於長期成長和創新至關重要。

核酸萃取儀器和試劑市場的促進因素與挑戰

核酸萃取儀器和試劑市場雖然受到推動其成長的各種因素的影響，但也面臨企業必須克服的若干挑戰。了解這些促進因素對於尋求最佳化策略並利用這個快速發展的行業中的新機會相關人員。

推動核酸萃取儀器和試劑市場發展的因素包括：

  • 診斷測試的需求不斷增加：診斷測試的需求不斷增加：遺感測染疾病的日益普及增加了對準確診斷測試的需求。這一趨勢推動了對可靠核酸萃取技術的需求，因為它們對於生產有效檢測和治療所需的高品質樣本至關重要。
  • 生物技術的進步：生物技術的快速進步正在推動核酸萃取方法方法的創新。自動化系統和以微珠為基礎的萃取等新技術正在提高效率和可靠性。這些創新不僅改善了實驗室工作流程，而且還滿足了研究人員和臨床醫生對高通量解決方案日益成長的需求。
  • 增加對基因組學的投資：基因組學研究投資的激增推動了對核酸萃取設備和試劑的需求。隨著越來越多的機構轉向基因組學進行個人化醫療和藥物開發，對先進提取技術的需求變得越來越重要，為市場相關人員提供了巨大的成長機會。
  • 分子診斷的監管支持：分子診斷的支持性法律規範正在推動市場成長。政府和監管機構正在鼓勵開發和採用基於核酸的檢測方法，進一步刺激對符合嚴格品質標準的萃取技術和試劑的需求。
  • 個人化醫療意識的增強：個人化醫療意識和實踐的增強正在產生對先進核酸提取解決方案的需求。隨著醫療保健轉向基於基因資訊的個人化治療，對高效、準確的提取方法的需求變得至關重要，從而推動了市場的擴張。

核酸萃取儀器及試劑市場的挑戰如下：

  • 先進技術高成本：核酸萃取市場面臨的關鍵挑戰之一是先進技術和自動化系統成本高。新興市場的小型實驗室和設施可能難以投資這種昂貴的設備，這限制了它們獲得高效萃取方法的機會。
  • 監管障礙：核酸萃取市場必須應對複雜的法規環境，這可能會延遲新產品的核准和商業化。遵守嚴格的品質和安全標準需要大量的資源和時間，這對試圖快速將創新解決方案推向市場的公司來說是一個挑戰。
  • 競爭與市場飽和：隨著核酸萃取技術的需求增加，市場競爭日益激烈。許多公司已經進入該領域，該領域可能會趨於飽和。為了保持市場佔有率並滿足不斷變化的客戶需求，公司必須提供差異化的產品並不斷創新。

受技術進步和診斷測試需求不斷成長的推動，核酸萃取設備和試劑市場充滿機會。儘管存在高成本、監管障礙和競爭等挑戰，但公司可以透過策略性地應對這些挑戰來取得成功。透過利用成長動力並有效克服挑戰，相關人員可以利用醫療保健和研究領域不斷變化的需求，為在這個充滿活力的市場中取得長期成功做好準備。

目錄

第1章執行摘要

第2章全球核酸萃取儀器與試劑市場：市場動態

  • 簡介、背景和分類
  • 供應鏈
  • 產業驅動力與挑戰

第3章市場趨勢與預測分析（2019-2031）

  • 宏觀經濟趨勢（2019-2024）及預測（2025-2031）
  • 全球核酸萃取儀器及試劑市場趨勢（2019-2024）及預測（2025-2031）
  • 全球核酸萃取儀器和試劑市場（按類型）
    • 裝置
    • 旋轉柱
    • 珠子/磁珠
    • 自動化核酸萃取系統
    • 萃取試劑套件、試劑和耗材
    • 其他
  • 全球核酸萃取儀器和試劑市場（按萃取類型）
    • DNA萃取
    • DNA/RNA萃取
    • RNA萃取
  • 全球核酸萃取儀器和試劑市場（依方法）
    • 基於解決方案的方法
    • 基於固相的方法
  • 全球核酸萃取設備和試劑市場（按最終用途）
    • 學術研究所
    • 醫院和診斷中心
    • 製藥和生物技術
    • CRO（委外研發機構）
    • 其他

第4章區域市場趨勢與預測分析（2019-2031）

  • 全球核酸萃取儀器及試劑市場（按地區）
  • 北美核酸萃取設備及試劑市場
  • 歐洲核酸萃取設備及試劑市場
  • 亞太核酸萃取設備及試劑市場
  • 其他地區核酸萃取設備及試劑市場

第5章 競爭分析

  • 產品系列分析
  • 營運整合
  • 波特五力分析

第6章 成長機會與策略分析

  • 成長機會分析
    • 全球核酸萃取儀器和試劑市場成長機會（按類型）
    • 全球核酸萃取儀器和試劑市場按萃取類型分類的成長機會
    • 全球核酸萃取儀器和試劑市場成長機會（按方法）
    • 全球核酸萃取儀器和試劑市場的成長機會（以最終用途）
    • 核酸萃取設備及試劑市場全球各區域成長機會
  • 全球核酸萃取設備及試劑市場新趨勢
  • 戰略分析
    • 新產品開發
    • 全球核酸萃取設備及試劑市場產能擴張
    • 全球核酸萃取儀器和試劑市場的企業合併
    • 認證和許可

第7章主要企業簡介

  • Thermo Fisher Scientific
  • F Hoffmann-La Roche
  • Merck Group
  • Corning Incorporated
  • Agilent Technologies
  • PerkinElmer
  • Illumina
  • Beckman Coulter
  • Bio-Rad Laboratories
  • Qiagen
簡介目錄

The future of the global nucleic acid extraction instrument and reagent market looks promising with opportunities in the academic research institute, hospitals & diagnostic centers, pharmaceutical & biotechnology, and contract research organization markets. The global nucleic acid extraction instrument and reagent market is expected to grow with a CAGR of 10.4% from 2025 to 2031. The major drivers for this market are the rising interest in customized treatment, the increase in the occurrence of chronic illnesses, and the growing development of medical diagnostics.

  • Lucintel forecasts that, within the type category, the instruments is expected to witness the highest growth.
  • Within this end use category, academic research institutes is expected to witness the highest growth.
  • In terms of regions, North America is expected to witness the highest growth.

Gain Valuable Insights for your business decisions with our comprehensive 150+ page report.

Emerging Trends in the Nucleic Acid Extraction Instrument and Reagent Market

The nucleic acid extraction instrument and reagent market is evolving rapidly, driven by technological advancements and increasing demand for accurate diagnostics. These emerging trends reflect the industry's response to the growing need for efficient, reliable, and scalable solutions across various applications, from clinical diagnostics to research.

  • Integration of Automation: Automation is becoming increasingly prevalent in nucleic acid extraction processes, reducing human error and increasing throughput. Automated systems enable laboratories to handle higher sample volumes with consistent results, improving efficiency and allowing for real-time monitoring of extraction protocols.
  • Miniaturization of Instruments: There is a growing trend toward the miniaturization of nucleic acid extraction instruments. Compact devices offer portability and ease of use, making them suitable for point-of-care testing and field applications. This shift enhances accessibility and reduces reagent consumption, aligning with sustainability goals.
  • Use of Magnetic Bead Technology: Magnetic bead-based extraction methods are gaining traction due to their efficiency and versatility. This technology simplifies the extraction process, enabling quicker and more effective isolation of nucleic acids while minimizing contamination risks. Its compatibility with various sample types drives widespread adoption across laboratories.
  • Focus on Cost-Effective Solutions: As demand for nucleic acid testing increases globally, there is a heightened focus on developing cost-effective extraction solutions. Manufacturers are innovating to provide affordable reagents and instruments, making high-quality nucleic acid extraction accessible to a broader range of laboratories, especially in emerging markets.
  • Emphasis on Quality Control: Quality control measures are becoming increasingly important in the nucleic acid extraction process. An enhanced focus on the standardization and validation of extraction protocols ensures reproducibility and reliability, particularly in clinical settings. This trend is vital for regulatory compliance and meeting the stringent demands of diagnostic applications.

The nucleic acid extraction market is poised for significant advancements driven by automation, miniaturization, and innovative technologies. As the demand for reliable and efficient diagnostic solutions grows, the industry is responding with cost-effective and high-quality products. These emerging trends enhance laboratory capabilities and improve accessibility for a broader range of users, including those in resource-limited settings. Ultimately, the ongoing evolution of this market will play a critical role in advancing molecular biology and clinical diagnostics, ensuring better health outcomes globally.

Recent Developments in the Nucleic Acid Extraction Instrument and Reagent Market

The nucleic acid extraction instrument and reagent market is undergoing rapid transformation, characterized by significant technological advancements and innovations. These developments enhance the efficiency, reliability, and accessibility of nucleic acid extraction methods, catering to diverse applications in research, diagnostics, and biotechnology.

  • Advancements in Automation: The integration of automated systems in nucleic acid extraction processes has revolutionized laboratory workflows. These systems minimize human error and significantly increase throughput, allowing labs to process larger sample volumes efficiently. Automation also enables real-time monitoring, ensuring consistent quality and performance across multiple runs.
  • Emergence of Integrated Solutions: There is a notable trend toward integrated platforms that combine nucleic acid extraction with downstream applications, such as PCR and sequencing. These all-in-one solutions streamline workflows, reduce sample handling steps, and enhance overall efficiency. By facilitating a seamless transition from extraction to analysis, integrated solutions are increasingly favored in both research and clinical settings.
  • Enhanced Reagent Formulations: Recent developments in reagent formulations have led to improved extraction efficiency and yield. Novel reagents are designed to optimize the binding and elution of nucleic acids, resulting in higher-quality samples. These enhancements address the needs of various applications, from clinical diagnostics to genetic research, ultimately supporting more reliable results.
  • Focus on Point-of-Care Testing: The demand for point-of-care (POC) testing has spurred innovations in nucleic acid extraction technologies. Portable and user-friendly devices are being developed to enable rapid testing in diverse settings, including remote areas. This trend addresses the urgent need for timely diagnostics, particularly in infectious disease outbreaks and resource-limited environments.
  • Sustainability Initiatives: Increasing awareness of environmental concerns is driving sustainability initiatives within the nucleic acid extraction market. Manufacturers are focusing on developing eco-friendly reagents and instruments that minimize waste and reduce environmental impact. This shift not only aligns with global sustainability goals but also appeals to laboratories striving to adopt greener practices.

The nucleic acid extraction instrument and reagent market is marked by key developments that enhance efficiency, integration, and sustainability. With advancements in automation, integrated solutions, and eco-friendly practices, the market is evolving to meet the growing demands of research and diagnostics. These innovations are critical for improving the reliability and accessibility of nucleic acid testing, ultimately contributing to better health outcomes and advancing scientific discovery. As the landscape continues to change, the industry is well-positioned for future growth and transformation.

Strategic Growth Opportunities for Nucleic Acid Extraction Instrument and Reagent Market

The nucleic acid extraction instrument and reagent market is ripe for growth, driven by advancements in technology and increasing demand for efficient diagnostic solutions. Companies can capitalize on several strategic opportunities that cater to evolving market needs and expand their reach across various sectors, including healthcare, research, and biotechnology.

  • Expansion into Emerging Markets: As healthcare infrastructure develops in emerging markets, there is growing demand for nucleic acid extraction technologies. Companies can strategically invest in these regions to offer affordable and accessible solutions tailored to local needs. Establishing partnerships with local distributors and healthcare providers can enhance market penetration and drive growth.
  • Development of Customized Solutions: Tailoring nucleic acid extraction instruments and reagents to meet specific applications and user needs presents significant growth potential. By collaborating with research institutions and clinical laboratories, manufacturers can design specialized products that cater to various sample types and extraction methods, enhancing user satisfaction and market competitiveness.
  • Integration of AI and Machine Learning: The integration of artificial intelligence (AI) and machine learning technologies into nucleic acid extraction processes offers opportunities for enhanced efficiency and accuracy. These technologies can optimize extraction protocols, improve yield, and reduce processing times, making them attractive features for modern laboratories seeking high-performance solutions.
  • Focus on Personalized Medicine: The rise of personalized medicine presents a unique opportunity for nucleic acid extraction companies. As genomics plays a crucial role in tailored therapies, the demand for high-quality nucleic acid extraction is increasing. By developing robust solutions that support genomic studies and precision medicine, companies can position themselves at the forefront of this growing market.
  • Partnerships and Collaborations: Strategic partnerships with biotech firms, academic institutions, and diagnostic companies can foster innovation and expand market reach. Collaborative efforts can facilitate the development of cutting-edge extraction technologies and broaden the application of nucleic acid testing in various fields, including cancer research, infectious disease diagnostics, and genetic studies.

The nucleic acid extraction instrument and reagent market offers numerous strategic growth opportunities, driven by technological advancements and increasing global demand. By focusing on emerging markets, customized solutions, and innovative technologies like AI, companies can position themselves for success in a competitive landscape. Additionally, collaborations and partnerships can enhance product offerings and expand market reach, ensuring that businesses are well-equipped to meet the evolving needs of healthcare and research sectors. As the market continues to evolve, seizing these opportunities will be crucial for long-term growth and innovation.

Nucleic Acid Extraction Instrument and Reagent Market Driver and Challenges

The nucleic acid extraction instrument and reagent market is influenced by various drivers that foster growth while facing several challenges that companies must navigate. Understanding these dynamics is essential for stakeholders looking to optimize their strategies and capitalize on emerging opportunities in this rapidly evolving sector.

The factors responsible for driving the nucleic acid extraction instrument and reagent market include:

  • Growing Demand for Diagnostic Testing: The increasing prevalence of genetic disorders and infectious diseases has heightened the demand for accurate diagnostic testing. This trend drives the need for reliable nucleic acid extraction technologies, as they are critical for producing high-quality samples necessary for effective testing and treatment.
  • Advancements in Biotechnology: Rapid advancements in biotechnology are propelling innovation in nucleic acid extraction methods. New technologies, such as automated systems and magnetic bead-based extraction, enhance efficiency and reliability. These innovations not only improve lab workflows but also cater to the growing needs of researchers and clinicians for high-throughput solutions.
  • Rising Investment in Genomics: The surge in investment in genomics research is driving demand for nucleic acid extraction instruments and reagents. As more institutions focus on genomics for personalized medicine and drug development, the need for advanced extraction technologies becomes increasingly crucial, presenting significant growth opportunities for market players.
  • Regulatory Support for Molecular Diagnostics: Supportive regulatory frameworks for molecular diagnostics are fostering market growth. Governments and regulatory bodies are encouraging the development and adoption of nucleic acid-based testing methods, which further stimulate demand for extraction technologies and reagents that meet stringent quality standards.
  • Increased Awareness of Personalized Medicine: The growing awareness and implementation of personalized medicine are creating a demand for advanced nucleic acid extraction solutions. As healthcare shifts towards tailored treatments based on genetic information, the need for efficient and accurate extraction methods becomes paramount, driving market expansion.

Challenges in the nucleic acid extraction instrument and reagent market are:

  • High Cost of Advanced Technologies: One significant challenge facing the nucleic acid extraction market is the high cost associated with advanced technologies and automated systems. Smaller laboratories and facilities in emerging markets may struggle to invest in these high-priced instruments, limiting their access to efficient extraction methods.
  • Regulatory Hurdles: The nucleic acid extraction market must navigate complex regulatory environments that can slow down the approval and commercialization of new products. Adhering to stringent quality and safety standards requires significant resources and time, posing challenges for companies seeking to bring innovative solutions to market quickly.
  • Competition and Market Saturation: As the demand for nucleic acid extraction technologies grows, the market is becoming increasingly competitive. Many players are entering the space, leading to potential saturation. Companies must differentiate their offerings and continuously innovate to maintain market share and address evolving customer needs.

The nucleic acid extraction instrument and reagent market presents a landscape rich with opportunities driven by technological advancements and increasing demand for diagnostic testing. While challenges such as high costs, regulatory hurdles, and competition exist, addressing these issues strategically can enable companies to thrive. By leveraging the growth drivers and navigating the challenges effectively, stakeholders can position themselves to capitalize on the evolving needs of the healthcare and research sectors, ensuring long-term success in this dynamic market.

List of Nucleic Acid Extraction Instrument and Reagent Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. Through these strategies nucleic acid extraction instrument and reagent companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the nucleic acid extraction instrument and reagent companies profiled in this report include-

  • Thermo Fisher Scientific
  • F Hoffmann-La Roche
  • Merck Group
  • Corning Incorporated
  • Agilent Technologies
  • PerkinElmer
  • Illumina
  • Beckman Coulter
  • Bio-Rad Laboratories
  • Qiagen

Nucleic Acid Extraction Instrument and Reagent by Segment

The study includes a forecast for the global nucleic acid extraction instrument and reagent market by type, extraction type, method, end use, and region.

Nucleic Acid Extraction Instrument and Reagent Market by Type [Analysis by Value from 2019 to 2031]:

  • Instruments
  • Spin Columns
  • Beads or Magnetic Beads
  • Automated Nucleic Acid Extraction Systems
  • Extraction Kits, Reagents & Consumables
  • Others

Nucleic Acid Extraction Instrument and Reagent Market by Extraction Type [Analysis by Value from 2019 to 2031]:

  • DNA Extraction
  • DNA or RNA Extraction
  • RNA Extraction

Nucleic Acid Extraction Instrument and Reagent Market by Method [Analysis by Value from 2019 to 2031]:

  • Solution-Based Methods
  • Solid-Phase-Based Methods

Nucleic Acid Extraction Instrument and Reagent Market by End Use [Analysis by Value from 2019 to 2031]:

  • Academic Research Institutes
  • Hospitals & Diagnostic Centers
  • Pharmaceutical & Biotechnology
  • Contract Research Organizations
  • Others

Nucleic Acid Extraction Instrument and Reagent Market by Region [Analysis by Value from 2019 to 2031]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

Country Wise Outlook for the Nucleic Acid Extraction Instrument and Reagent Market

The nucleic acid extraction instrument and reagent market is witnessing significant growth across key regions, fueled by advancements in technology and increasing demand for efficient diagnostic solutions. In the U.S., innovations in automation are enhancing extraction processes, while China is ramping up domestic production and affordability. Germany leads with a focus on AI integration, and India is expanding through collaborations to meet diverse needs. Meanwhile, Japan's emphasis on precision and miniaturization is driving the development of compact, high-quality systems. Together, these trends reflect a dynamic and rapidly evolving landscape in the nucleic acid extraction industry.

  • U.S.: In the U.S., the nucleic acid extraction market is experiencing significant growth driven by advancements in automation and efficiency. Companies are investing in innovative technologies to enhance extraction processes, aiming to meet the increasing demand for rapid and reliable diagnostics, particularly in the context of infectious diseases.
  • China: China has seen a surge in domestic production of nucleic acid extraction instruments, supported by government initiatives to bolster biotechnology sectors. The focus on affordable, high-throughput solutions is driving competition, with local companies rapidly adopting international standards to enhance quality and reliability.
  • Germany: Germany continues to be a leader in the nucleic acid extraction market, with a strong emphasis on research and development. German manufacturers are integrating AI and machine learning into their instruments to optimize extraction protocols, ensuring higher yields and improved accuracy, thereby supporting both clinical and research applications.
  • India: In India, the nucleic acid extraction market is expanding due to increasing investment in biotechnology and healthcare infrastructure. Local firms are collaborating with international partners to enhance their product offerings, focusing on cost-effective solutions that cater to the diverse needs of hospitals and research institutions.
  • Japan: Japan is advancing in the nucleic acid extraction field through innovations in precision and miniaturization. The country's strong focus on automation and robotics in laboratory processes is leading to the development of compact, efficient extraction systems, enhancing throughput while maintaining high-quality standards for both research and clinical diagnostics.

Features of the Global Nucleic Acid Extraction Instrument and Reagent Market

Market Size Estimates: Nucleic acid extraction instrument and reagent market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.

Segmentation Analysis: Nucleic acid extraction instrument and reagent market size by various segments, such as by type, extraction type, method, end use, and region in terms of value ($B).

Regional Analysis: Nucleic acid extraction instrument and reagent market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, extraction types, methods, end uses, and regions for the nucleic acid extraction instrument and reagent market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the nucleic acid extraction instrument and reagent market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this market or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the nucleic acid extraction instrument and reagent market by type (instruments, spin columns, beads or magnetic beads, automated nucleic acid extraction systems, extraction kits, reagents & consumables, and others), extraction type (DNA extraction, DNA or RNA extraction, and RNA extraction), method (solution-based methods and solid-phase-based methods), end use (academic research institutes, hospitals & diagnostic centers, pharmaceutical & biotechnology, contract research organizations, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Nucleic Acid Extraction Instrument and Reagent Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2019 to 2031

  • 3.1. Macroeconomic Trends (2019-2024) and Forecast (2025-2031)
  • 3.2. Global Nucleic Acid Extraction Instrument and Reagent Market Trends (2019-2024) and Forecast (2025-2031)
  • 3.3: Global Nucleic Acid Extraction Instrument and Reagent Market by Type
    • 3.3.1: Instruments
    • 3.3.2: Spin Columns
    • 3.3.3: Beads or Magnetic Beads
    • 3.3.4: Automated Nucleic Acid Extraction Systems
    • 3.3.5: Extraction Kits, Reagents & Consumables
    • 3.3.6: Others
  • 3.4: Global Nucleic Acid Extraction Instrument and Reagent Market by Extraction Type
    • 3.4.1: DNA Extraction
    • 3.4.2: DNA Or RNA Extraction
    • 3.4.3: RNA Extraction
  • 3.5: Global Nucleic Acid Extraction Instrument and Reagent Market by Method
    • 3.5.1: Solution-Based Methods
    • 3.5.2: Solid-Phase-Based Methods
  • 3.6: Global Nucleic Acid Extraction Instrument and Reagent Market by End Use
    • 3.6.1: Academic Research Institutes
    • 3.6.2: Hospitals & Diagnostic Centers
    • 3.6.3: Pharmaceutical & Biotechnology
    • 3.6.4: Contract Research Organizations
    • 3.6.5: Others

4. Market Trends and Forecast Analysis by Region from 2019 to 2031

  • 4.1: Global Nucleic Acid Extraction Instrument and Reagent Market by Region
  • 4.2: North American Nucleic Acid Extraction Instrument and Reagent Market
    • 4.2.1: North American Market by Type: Instruments, Spin Columns, Beads or Magnetic Beads, Automated Nucleic Acid Extraction Systems, Extraction Kits, Reagents & Consumables, and Others
    • 4.2.2: North American Market by End Use: Academic Research Institutes, Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology, Contract Research Organizations, and Others
  • 4.3: European Nucleic Acid Extraction Instrument and Reagent Market
    • 4.3.1: European Market by Type: Instruments, Spin Columns, Beads or Magnetic Beads, Automated Nucleic Acid Extraction Systems, Extraction Kits, Reagents & Consumables, and Others
    • 4.3.2: European Market by End Use: Academic Research Institutes, Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology, Contract Research Organizations, and Others
  • 4.4: APAC Nucleic Acid Extraction Instrument and Reagent Market
    • 4.4.1: APAC Market by Type: Instruments, Spin Columns, Beads or Magnetic Beads, Automated Nucleic Acid Extraction Systems, Extraction Kits, Reagents & Consumables, and Others
    • 4.4.2: APAC Market by End Use: Academic Research Institutes, Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology, Contract Research Organizations, and Others
  • 4.5: ROW Nucleic Acid Extraction Instrument and Reagent Market
    • 4.5.1: ROW Market by Type: Instruments, Spin Columns, Beads or Magnetic Beads, Automated Nucleic Acid Extraction Systems, Extraction Kits, Reagents & Consumables, and Others
    • 4.5.2: ROW Market by End Use: Academic Research Institutes, Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology, Contract Research Organizations, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Nucleic Acid Extraction Instrument and Reagent Market by Type
    • 6.1.2: Growth Opportunities for the Global Nucleic Acid Extraction Instrument and Reagent Market by Extraction Type
    • 6.1.3: Growth Opportunities for the Global Nucleic Acid Extraction Instrument and Reagent Market by Method
    • 6.1.4: Growth Opportunities for the Global Nucleic Acid Extraction Instrument and Reagent Market by End Use
    • 6.1.5: Growth Opportunities for the Global Nucleic Acid Extraction Instrument and Reagent Market by Region
  • 6.2: Emerging Trends in the Global Nucleic Acid Extraction Instrument and Reagent Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Nucleic Acid Extraction Instrument and Reagent Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Nucleic Acid Extraction Instrument and Reagent Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Thermo Fisher Scientific
  • 7.2: F Hoffmann-La Roche
  • 7.3: Merck Group
  • 7.4: Corning Incorporated
  • 7.5: Agilent Technologies
  • 7.6: PerkinElmer
  • 7.7: Illumina
  • 7.8: Beckman Coulter
  • 7.9: Bio-Rad Laboratories
  • 7.10: Qiagen